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CASE REPORT
Acute kidney injury on chronic kidney disease: from congestive heart failure
to light chain deposition disease and cast nephropathy in multiple myeloma
Sana Shaikh a, Christian Nwankwob, Alexandre Lacassea and Steven Chengc
aDepartment of Internal Medicine, SSM St. Mary’s Hospital, St. Louis, St. Louis, MO, USA; bDepartment of Nephrology, SSM St. Mary’s
Hospital, St. Louis, St. Louis, MO, USA; cDepartment of Nephrology, Washington University School of Medicine, St. Louis, MO, USA
ABSTRACT
Acute on chronic renal failure is a commonbut notably broad diagnosis. We present a 64-year-old
man with a history of diastolic heart failure and chronic kidney disease, admitted for an elevated
creatinine. History and physical examination were suggestive of decompensated heart failure;
however, the careful interpretation of urinalysis rendered the diagnosis of multiple myeloma. On
renal biopsy, the patient was found to have light chain deposition disease with cast nephropathy.
Combination lesions in multiple myeloma are rare and require diligent histopathology for
detection, including light microscopy, immunofluorescence and electron microscopy. These
patients portray different demographics, renal manifestations, oncologic characteristics and
outcomes, and hence, further studies isolating these combined lesions are warranted.
Abbreviations: CKD: chronic kidney disease; CN: cast nephropathy; CT: computerized tomo-
graphy; EDD: electron-dense deposits; EM: electron microscopy; IF: immunofluorescence; FLC:
free light chain; LC: light chain; LCDD: light chain deposition disease; MIDD: monoclonal
immunoglobulin deposition disease; MM: multiple myeloma; LM: light microscopy; NGS:
nodular glomerulosclerosis; κ: kappa; λ: lambda.
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Free light chains (FLCs) are overproduced by abnormal
B-cells in plasma cell dyscrasias and other lymphopro-
liferative disorders [1]. They are filtered by the glomer-
uli, reabsorbed in the proximal tubules and degraded in
the tubular cells, making the kidney a prominent
deposition target [2]. Light chain (LC) deposition con-
tributes to renal insufficiency in multiple myeloma
(MM) by causing three main patterns of injury: cast
nephropathy (CN), monoclonal immunoglobulin
deposition disease (MIDD) and amyloidosis [3]. Light
chain deposition disease (LCDD) is the most prevalent
variant of MIDD. Lesions in combination are scarcely
observed, with LCDD-CN being relatively more fre-
quent and LCDD-amyloid being rare [1,3,4].
2. Case report
A 64-year-old man with past medical history of diastolic
heart failure, stage 3 chronic kidney disease (CKD) of
unknown etiology, interstitial lung disease and pulmon-
ary hypertension with chronic hypoxemic respiratory
failure, recurrent nephrolithiasis, morbid obesity and 65-
pack-year tobacco abuse presented with an elevated crea-
tinine on outpatient laboratory investigation. Associated
symptoms included progressive lower extremity swelling,
weight gain and chronic, spontaneous and intermittent
gross hematuria. Vital signs were stable. Physical exam-
ination was pertinent for jugular venous distention and
symmetric bilateral pitting pedal edema. Laboratory data
was significant for creatinine of 5 mg/dl [0.8–1.3 mg/dl]
from baseline value of 1.4 mg/dl a month prior to
encounter, elevated blood urea nitrogen (42 [8–25 mg/
dl]), hyperphosphatemia (6.2 [2.3–4.5 mg/dl]), elevated
N-terminal pro B-type natriuretic peptide (7162 [0–299
pg/ml]), normocytic normochromic anemia (10.8
[13–17.5 gm/dl]) and normal albumin. Urine studies
disclosed proteinuria (2+), gross hematuria (3+), transi-
ent normoglycemic glycosuria (1+), spot protein/creati-
nine ratio of 4.7 and a calculated fractional excretion of
urea of 52%. Chest X-ray showed bilateral reticular opa-
cities, traction bronchiectasis and bullous apical disease.
Noncontrast computerized tomography (CT) of the chest
confirmed bibasilar nonspecific interstitial pneumonia
pattern, combined pulmonary fibrosis and emphysema
and bibasilar cystic changes representing amyloidosis or
pneumatoceles. Retroperitoneal ultrasound demon-
strated a 16-cm right kidney, 16.4-cm left kidney, right-
sided renal parenchymal disease and bilateral nonob-
structing nephrolithiasis.
Further investigations revealed an abnormal
restricted peak in the gamma region on serum protein
electrophoresis, elevated kappa (κ)-FLC (477
[0.33–1.94 mg/dl]), elevated κ- to lambda (λ)-FLC
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ratio (229 [0.26–1.65]), presence of immunoglobulin
G κ monoclonal protein on immunofixation, elevated
beta-2 microglobulin (21.4 [1–2.5 mg/L]), high normal
immunoglobulin G (1568 [700–1600 mg/dl]) as well as
anemia of chronic disease. Renal biopsy was consistent
with the diagnosis of κ-LCDD, CN and focal global
glomerulosclerosis (3/19, 16%) (Figure 1). Bone mar-
row aspirate and core biopsy affirmed plasma cell
neoplasm comprising 30% of marrow cellularity.
Flow cytometry showed 6% of events in the plasma
cell gate which were κ restricted (96%), CD19 negative
(95%) and CD56 positive (97%). Positron emission
tomography-CT was without bony lytic lesions.
Kidney function steadily declined and after the onset
of oliguria, intermittent hemodialysis was initiated.
The patient was discharged with nephrology and
hematology follow-up. As an outpatient, therapy with
cyclophosphamide, dexamethasone and bortezomib
was administered. Renal function, including serum
creatinine and urine output, began to improve.
Hemodialysis was discontinued after five months. At
one year, serum creatinine was 2.5 mg/dl, κ-FLC was
8.64 and κ/λ ratio was 2.65.
3. Discussion
Admission diagnosis for this patient was acute cor
pulmonale or decompensated right-sided congestive
heart failure. Following intravenous diuresis, subjec-
tive improvement was reported and there was an
appropriate response in the urine output. However,
certain subtle laboratory findings pointed towards an
alternative diagnosis. Serial creatinine measurements
continued to trend upwards in spite of several diure-
tic regimen adjustments. Urine protein quantification
showed nephrotic-range proteinuria, although falsely
elevated by concomitant red blood cell lysis.
Hematuria was attributed to trauma from renal cal-
culi, but nephritic syndromes could not be excluded.
The presence of glycosuria in the setting of normo-
glycemia and normal hemoglobin A1c was concern-
ing for proximal tubular dysfunction. Despite
preexisting CKD, both kidneys were paradoxically
enlarged on ultrasound. In an attempt to find
a unifying diagnosis, serum and urine protein elec-
trophoresis and immunofixation were sent, and find-
ings were consistent with an immunoglobulin
overproduction process. Diagnosis of MM was thus
obtained in the absence of hypercalcemia, albumino-
cytologic dissociation, bony lytic lesions, weight loss
or fatigue. Renal lesion identified on biopsy was
a combination of LCDD and CN. Amyloidosis was
suspected based on kidney size, potential amyloid-
associated cystic lung disease and presence of diasto-
lic heart failure, but this was not settled by biopsy.
LCDD-CN is a histopathologic diagnosis. It can be
easily missed without meticulous and sequential light
microscopy (LM), immunofluorescence (IF) staining
for κ- and λ-LC and electron microscopy (EM)
(Table 1, Supplementary material). The various per-
mutations and combinations of microscopic findings
make the diagnosis challenging. First, the LM findings
associated with LCDD-CN are dominated by the CN
component, with the presence of fractured periodic
acid-Schiff-negative tubular casts [3,5]. Nodular
Figure 1. Histopathology seen on renal biopsy.
Light microscopy – The non-sclerotic glomeruli show nodular glomerulosclerosis. The nodules are Periodic acid-Schiff (PAS) (a) and silver
positive (b). Numerous periodic acid-Schiff-negative fuchsinophilic casts are present within the tubular lumens, some of which have a cracked
appearance and associated inflammation (c). The cortical tubulointerstitial tissue has moderate interstitial edema (d). Immunofluorescence –
Frozen sections of tissue submitted show no glomeruli. On a scale of 0–3+, tubular casts stain with kappa light chain (3+, focal) (e) and lambda
light chain (1+, focal) (f). Tubular basement membranes stain with kappa light chain (2+) (e) and are negative for lambda light chain (f).
Electron microscopy – The two glomeruli evaluated show punctate granular subendothelial electron-dense deposits that have a linear
distribution throughout the glomerular basement membranes (g). The tubular basement membranes show similar powdery granular electron-
dense deposits (h).
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glomerulosclerosis (NGS), the lesion most suggestive
of LCDD, is infrequently identified [2,5,6]. This could
be due to an earlier presentation with CN-induced
renal failure and insufficient NGS development time
or decreased sclerogenicity of the pathogenic LC in
this entity [6]. Second, IF is the most sensitive techni-
que for detecting LC deposition, but EM oftentimes
reveals typical finely granular electron-dense deposits
(EDDs) in IF-negative cases [2,5]. Structural changes
in the antigenic sites on the LC and masked antibody
recognition epitopes may play a role [2]. Third, EM
alone may conceal the diagnosis due to differences in
LC structure. EDDs are more likely with κ-LC than λ-
LC [2]. Deposits may be focally distributed and absent
in the available EM sample or the LC aggregation may
be insufficient for visualization at an ultrastructural
level [2,5]. Repeat renal biopsies may show persistent
LC deposits in treated and transplanted patients [7].
Lin et al. reported differences in demographics,
presenting renal manifestations, oncologic character-
istics and outcomes in patients with LCDD-CN in
comparison to pure MIDD [6]. Several indices varied:
mean age was higher (67.1 versus 57.4 years), mean
24-hour proteinuria was lower (2.2 versus 4.2 g/day),
incidence rates of acute kidney injury and dialysis
dependence at the time of renal biopsy were higher
(82% versus 30% and 64% versus 26%, respectively)
and the incidence of MM was also higher (91% versus
39%). Pozzi et al. found LCDD-CN to be the only
histological feature associated with a worse renal out-
come [2]. Zand et al. had similar findings in patients
with LCDD-CN as compared to those with LCDD
alone [8]. The rate of acute renal failure at the time of
renal biopsy was higher (54% versus 30%), as was the
incidence of MM (100% versus 69%) and overall
mortality (69% versus 29%). Treatment goals for
LCDD-CN include improvement and stabilization of
renal function as well as prevention of extrarenal
deposits [7]. These may be seen in the heart, liver,
spleen and peripheral nervous system [2,7,9].
Therapy for MM has been well described in oncology
literature. In those requiring renal replacement ther-
apy, both hemodialysis and peritoneal dialysis offer
similar survival statistics [2]
4. Conclusion
LCDD-CN has not been well characterized or distin-
guished as a group in previous studies. Establishing
diagnosis requires diligent LM, IF and EM evaluation.
Patients tend to have worse renal as well as overall
survival. Although reported to be a prevalent combi-
nation of renal lesion, LCDD-CN remains sporadi-
cally documented in the medical literature.
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